Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.13 USD | -0.03% | -0.87% | -10.16% |
May. 09 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 28 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2M | Capitalization | 1.79B |
---|---|---|---|---|---|
Net income 2024 * | -316M | Net income 2025 * | -361M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 897 x |
P/E ratio 2024 * |
-5.82
x | P/E ratio 2025 * |
-6.91
x | Employees | 169 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.18% |
1 day | +0.26% | ||
1 week | -0.73% | ||
Current month | +0.29% | ||
1 month | -2.40% | ||
3 months | -9.13% | ||
6 months | +68.84% | ||
Current year | -10.16% |
Managers | Title | Age | Since |
---|---|---|---|
Brendan Eckelman
FOU | Founder | 45 | 10-03-31 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 10-03-31 |
Kelly Deck
DFI | Director of Finance/CFO | 44 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Kayyem
BRD | Director/Board Member | 60 | 18-03-31 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 10-03-31 |
Kimberly Manhard
BRD | Director/Board Member | 64 | 20-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - | |
0.09% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.04% | 1,487 M€ | +7.21% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 34.14 | 0.00% | 1 492 428 |
24-05-14 | 34.14 | +0.26% | 324,764 |
24-05-13 | 34.05 | -0.70% | 1,260,074 |
24-05-10 | 34.29 | -1.15% | 506,507 |
24-05-09 | 34.69 | +0.73% | 1,116,251 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.16% | 1.79B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- INBX Stock